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Summary The ability of tumour necrosis factor a (TNF-a), a potent endogenous inflammatory agent, to promote malignant transformation of
Syrian hamster embryo cells (SHE) initiated by a 0.5-Gy dose of a-particles was investigated. Opsonized zymosan particles, which were
phagocytosed by a human macrophage-like cell line, triggered TNF-a production from U937 cells. This cell supernatant could significantly
increase the transformation frequency (TF) of primary SHE cells previously irradiated by a 0.5-Gy dose of a-particles. The TF decreased
significantly if monoclonal antibody against TNF-a was added to the supernatant. Similarly, recombinant human TNF-a (rhTNF-a) increased
the TF of alpha-irradiated primary SHE cells to an even greater extent. Addition of TNF-a to subcultures of irradiated SHE cells permitted the
continuous propagation of these primary cells. In contrast, both TNF-a-treated control and a-irradiated cells without subsequent TNF-a
treatment senesced after 7-15 passages. Irradiated SHE cells treated continuously with TNF-a could be subcultured over 40 passages and
produced fibrosarcomas upon inoculation into nude mice. Our results provide the first evidence that TNF-a released by activated
macrophages may contribute to the process of malignant transformation initiated by low-dose a-particles.
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The association between chronic inflammation and increased
predisposition to the development of tumours has been known for
many years (Templeton, 1975). This enhancement may be medi-
ated by agents released from inflammatory cells at sites ofinflam-
mation (Floyd, 1990; Zimmerman andCerutti, 1984; Bennett et al,
1993) where numerous factors are likely to be present, including
active oxygen species, arachidonic acid metabolites, nitric oxide,
interleukins, tumour necrosis factor (TNF) and platelet-activating
factor, etc. In this paper, we present evidence showing the promo-
tional effect ofrecombinant human TNF-a (rhTNF-a) andTNF-a
released from activated macrophage-like cell line U937 using a
well-established in vitro transformation assay.
TNF-a is a cytokine produced mainly by macrophages and
promotes a variety of physiological responses, such as inflamma-
tion, immunoregulation, cachexia, and mitogenesis (Old, 1985;
Vassalli, 1992). Recent studies have demonstrated that rhTNF-a
was found to be an endogenous promoter by its biochemical
mimicry of okadaic acid and significantly stimulated the transfor-
mation incidence of BALB/3T3 cells initiated with 3-methyl-
cholanthrene (Fujiki and Suganuma, 1994; Komori et al, 1993),
and that inhibition ofTNF-a mRNA expression and its release is a
new process of cancer prevention (Suganuma et al, 1996). We
have previously reported the relationship between pneumonia
and lung cancer induced by inhaled plutonium dioxide in rats in
which chronic inflammation resulted in neutrophils and alveolar
macrophages accummulation in pulmonary alveoli (Hu et al,
1989; Xie et al, 1989). It was in the vicinity ofthese fibroid areas
that neoplastic nodules frequently developed. These results
attracted our attention as a possible link between endogenous
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TNF-a released by activated macrophages and cancer induced by
a-particles.
In this paper, we sought to determine whether Syrian hamster
embryo (SHE) fibroblasts, one of the most widely used cell lines
for the study of neoplastic transformation, are promoted by
endogenous TNF-a and rhTNF-a.
MATERIALS AND METHODS
Cell, cell culture and passage experiment
Golden hamster embryo on the 13th day of gestation served as a
source of cells for the experiments. Embryos were surgically
removed, minced and dissociated as describedpreviously (Dipaolo,
1980). Primary cultures were established by seeding 2 x 106 cells in
35-cm2 glass flasks in F12 medium (Sigma, Chemicals, St Louis,
MO, USA) supplemented with 10% fetal bovine serum (Gibco,
Grand Island, NY, USA) together with penicillin (50 units ml-1) and
streptomycin (50 jg ml-'). The cells were incubated at 37°C in a
humidified 5% carbon dioxide-air incubator. When 4 x 105 cells
seeded in each flask grew to 2 x 106 cells, it was defined as one
passage. The population doubling number (PDN) was calculated
at each passage as follows: PDN = Log (N,1Nd)/Log2 (No and N,
are the number of cells inoculated and at the end of one passage
respectively; Suzuki et al, 1989).
Irradiation procedure
The 238Pu was deposited on a stainless-steel disc over an area of
1589 mm2 and covered with a thin plastic film to prevent it from
dropping. The uniformity of the activity on the sources was deter-
mined by CR-39 track-etch, and the track-etch diagram showed that
a-particles on the field ofcells were evenly distributed (Zhang et al,
1996). The radiation dose from the a-source was calculated for
a plane source as previously described (Crawford-Brown and
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Shyr, 1987). For the 238Pu a-source (3.33 MBq of energy of
5.34 MeV), the area ofthe plane was 1589 mm2, and the a-particles
range in tissue was 39.2 jm. The calculated dose rate for the source
used in this study was 1.9 Gymin7l tocells located 8.67 jm from the
plane source. In this calculation it was assumed that the mean
distance fromthe sourcetothe centreofthe cell nucleus was 8.67 jm
(nuclei ofattached SHEcells are spherules 4.67 jminradius, and are
separated from the source by 4 jm of Hostanphan films, Kalle
Chemie Wiesbaden, a gift from Dr L Hieber). The dose rate was
calculated by integrating the contributions from the plane source
within the range of the a-particles (Crawford-Brown and Shyr,
1987). Linear energy transfer (LET) values as a function of the
distance travelled by the a-particles were taken from data published
previously (Walsh, 1970).
For irradiation ofcultured cells using an electroplated source of
238Pu, the cells were plated in specially constructed culture dishes
consisting of a glass ring of 5-cm-diameter and a foil bottom of
2 jm Hostaphan. In order to avoid settlement of cells at the edge
of the dishes where they might not be exposed uniformally
because of the limited range of the a-particles, the cells were
plated in the centre area (3.8-cm-diameter) of the dishes in 0.5 ml
of medium. After incubation for 3 h, when the cells were already
attached on the foil bottom, 4.5 ml of culture medium was added
to each of the dishes (Hieber et al, 1987). Twenty-four hours after
plating, cultures were irradiated for 16s by placing the hostaphan-
bottomed dishes containing cells and culture medium directly onto
an electroplated source covered with a piece of hostaphan to
prevent contamination (Thomassen et al, 1990).
Preparation of U937 cell supernatant and assay of TNF-a
Preparation of opsonized zymozan, the stimulation of U937 cells
and the assay of TNF-a were carried out as described previously
(Jiang et al, 1992). In this experiment, 0, 1, 5, 10 and 15 mg ml-1
opsonized zymozan particles were selected to stimulate U937
cells. Briefly, 2 ml of human mixed serum (A:B:O = 1:1:1) were
added to previously cooled zymozan particles and incubated for
30 min at 37°C. To remove excess serum, the preparation was
washed ten times in balanced salt solution (BSS), and U937 cells
(1 x 106 ml-') were cultured with the opsonized zymozan particles
for 24 h at 370C in 5% carbon dioxide. At the end of this incuba-
tion, the supernatant was harvested by centrifugation for 10 min at
2000 r.p.m. and stored at-80'C until use. The cytotoxic activity of
TNF-a was determined by standard bioassay using the TNF-a-
sensitive cell line L929 cells as described previously (Tomkins et
al, 1992). Briefly, L929 cells were incubated overnight in multi-
well plates to form a confluent monolayer. Both supematant and
standard TNF-a (a gift from Professor Peifeng Sen, Institute of
Basic Medicine, Beijing, China) were serially diluted with F12
medium containing 1 jg ml-' actinomycin D (final concentration).
The diluted standard TNF-a and supematant were added to the
plates and incubated at 370C in 5% carbon dioxide for 24 h. The
plates were then fixed in buffered formalin for S min and stained
with 0.5% crystal violet for 10 min. After washing, the plates were
read on a Titertek multiscan at 540 nm. The TNF-a activity was
calculated in a unit(1 U) that resulted in 50% killing ofL929 cells.
Cytotoxic neutralization of TNF-a by monoclonal
anti-TNF-a antibody
Cytotoxic neutralization of TNF-a by anti-TNF-a antibody was
carried out as described previously (Galloway et al, 1991). Briefly,
an equal volume of TNF-a at a final concentration of 600 U ml-'
in the media containing 1 jg ml-' actinomycin D was added to
the antibodies, which were serially diluted from 20 jg ml-1 to
0.01 ig ml-' with the same media. After incubation at room
temperature for 2 h, 50 jl ofthe antibody/TNF mixture was added
to the L929 cultures in 96-well flat-bottomed microtitre plates
containing 50 jl of F12 media supplemented with penicillin-
streptomycin. The cultures were then transferred to a 37°C
incubator. After overnight incubation, TNF-a activity was assayed
as above.
Transformation assay
Primary SHE cells were trypsinized immediately after irradiation
and plated on to feeder cells at the density indicated. Feeder
cultures at a density of 2.8 x 103 per cm2 growth area were
prepared by irradiating primary SHE cells with a 70-Gy dose of
y-rays. Irradiated SHE cells were plated onto feeder culture in
35-cm2, glass flasks at densities depending on the dose to which
they were exposed (0 Gy, 20 cells cm-2, 0.5 Gy, 55 cells cm-2).
Two days after irradiation, rhTNF-a was added to the medium of
the irradiation group and the non-irradiation group so that the final
concentration ofrhTNF-a was 600 U ml-'.After initial addition of
rhTNF-a to the cultures, the medium was not changed until the
experiments were terminated. In a similar manner, U937 cell
supernatant and U937 cell supematantlanti-TNF mixture were
added to the medium, and the final concentration of TNF-a in the
medium was 500 U ml-'. After incubation for 8 days, cells were
fixed by methanol and stained with 10% giemsa. Transformed and
normal foci were distinguished using criteria described previously
(Borek and Hall, 1973; Pienta et al, 1981). Type 2 and 3 foci were
scored as transformants.
MTT assay for cell proliferation
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide,
Sigma) assay was used to measure cell proliferation (Mosmann,
1983). Briefly, cells were seeded into microtitre plates at density
of 1 x 104 per well. The plates were incubated at 370C in 5%
carbon dioxide for 48 h. The reaction was then stopped using 10 jl
of 10% sodium dodecyl sulphate (SDS) in 0.1 N hydrochloric acid.
After allowing at least 4 h to solubilize the MTT precipitate, the
plates were read spectrophotometrically at 540 nm. The results
shown were means ± standard errors from triplicate determinations.
Soft-agar growth
To determine the anchorage independence of the cells, we used a
soft-agar method as previously reported (Suzuki et al, 1983).
Briefly, cells were trypsinized, suspended in 0.2% agar medium
containing 20% serum, and seeded on top of a 0.5% base layer at
2 x 105 cells per dish. Ten dishes for each sample (2 x 106 per
sample) were prepared and incubated in 5% carbon dioxide at
37°C. After 2 weeks, colonies more than 0.1 mm in diameter were
counted under a dissecting microscope.
Assay fortumorigenicity
A total of 5 x 106 cells suspended in 0.2 ml of PBS (phosphate-
buffered saline) were injected subcutaneously into three nude
mice (Academy ofPreventive Medicine, Beijing, China) for each
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Table 1 Promoting effect of TNF-a in SHE cell transformation induced by a-particlesa
Dose TNF-a Surviving Number of dishes with focU Total number Transformation frequencyc
(Gy) (U ml-,) fractionb number of dishes examined of foci (mean ± s.e. per 103 survivors)
0 0 1 5/32 6 1.42 ± 0.58
0 600 1.2 ± 0.17 2/29 4 1.23 ± 0.50
0.5 0 0.33 ± 0.06 8/31 8 2.26 ± 0.80
0.5 600 0.42 ± 0.03 14/28 19 4.48 ± 1.07d
aPooled results of three separate experiments showing the same data trends. Freshly prepared SHE cells were used in the experiments, control plating
efficiency = 33%. bThe total number of colonies/the total number of plating cells x plating efficiency (PE) in control group. cThe total number of transformed
clones/the total number of clones. dStatistical analysis (Student t-test): P< 0.01 vs the groups above.
Table 2 Neutralization of tumour-promoting activity of U937 cell supernatant in SHE cell transformation by anti-TNF-aa
Dose U937 cell Anti-TNF-a Surviving Number of dishes with Total number Transformation frequency
(Gy) supernatantb antibodyc fraction foci/number of dishes of foci (mean ± s.e. per 103 survivors)
examined
0 - - 1 0/9 0 0
0 + - 0.96 ± 0.26 0/10 0 0
0 - + 0.78 ± 0.23 0/10 0 0
0 + + 0.60±0.22 0/9 0 0
0.5 - - 0.48 ± 0.09 1/10 1 1.37± 1.37
0.5 + - 0.43±0.12 8/10 11 16.4±4.59d
0.5 - + 0.52 ± 0.14 1/9 1 1.35 ± 1.35
0.5 + + 0.27 ± 0.08 2/8 2 6.00 ± 4.30e
aThawed frozen SHE cells were used in the experiments, control plating efficency = 6.7%. bContaining 500 U ml-' TNF-a at final concentration in the culture.
c2gg ml-' at final concentration in theculture. dStatistical analysis (Student t-test): P< 0.01, vs irradiation group above. ep< 0.05, vs irradiation group or
irradiation + U937 cell supernatant group.
transformed cell line tested. Animals were inspected weekly and
tumours more than 1 cm in diameterafter 3 months were scored as
positive tumours. Each tumour was identified by histopathological
examination. Non-treated SHE cells and human hepatoma cell line
BEL7402 were used as negative and positive controls and were
injected into nude mice in a similar manner.
RESULTS
RhTNF-a increased the TF ofSHE cells exposed to a 0.5 Gy dose
of a-particles by twofold, but it had no obvious effect on
unexposed SHE cells, as shown in Table 1. Opsonized zymozan
particles, which were phagocytosed by U937 cells, triggered their
production ofTNF-a. This cell supernatant provided a convenient
source of human TNF-a for experimental uses. In this study,
maximal production of TNF-a was achieved at approximately
10 mg ml opsonized zymozan particles, which produced approx-
imately 2200 U ml-1 TNF-a L929 cytotoxic activity (mean =
2266 U ml-1, s.e. = 27, n = 3). The U937 cell supematant
(containing 500 U ml- TNF-a at a final concentration in the
cultures) increased the TF by approximately tenfold as shown in
Table 2. To protect against TNF-a, 0.01, 0.1, 1, 2, 4 and 8 jg ml-1
anti-rhTNF-a antibody were used to neutralize the cytotoxicity
induced by 600 U ml-1 TNF-a. It was found in the experiments
(n = 3) that 2-8 gg ml-l antibody could neutralize 600 U ml-1
TNF-a cytotoxity completely. The TF decreased significantly
when anti-rhTNF-a antibody of 2gg ml- was added, but in this
case the TF was still higher than that of cells exposed to 0.5 Gy
a-particles (Table 2). Based on their molar concentrations, the
promoting activities of rhTNF-a were about 100 times stronger
than that ofPMA (data not shown).
After confirming that both rhTNF-a and TNF-a released from
U937 cells promote radiation-induced quantitative cell transfor-
mation, a series ofpassage experiments were carried out to further
characterize their effects on growth kinetics. The passage experi-
ments were divided into four groups: (a) the primary SHE cells;
(b) the primary SHE cells continuously treated with rhTNF-a;
(c) the SHE cells exposed to a-particles only at a dose of 0.5 Gy;
and (d) the SHE cells exposed to a-particles at a dose of 0.5 Gy
and continuously treated with rhTNF-a. These four culture groups
were subcultured in parallel. It was found that only the SHE cells
exposed to 0.5 Gy a-particles and treated with rhTNF-a were able
to be subcultured continuously up to the sixtieth passage. In
contrast, cells from other groups could not be subcultured beyond
the 7-15th passages. The alterations in growth kinetics were
expressed as the accumulated proliferation doubling number
(PDN) ofdifferent passages, as shown in Figure 1.
Cultures exposed to a-particles and treated with rhTNF-a
were serially passaged. Cells at the 30th passage were seeded
into culture flasks at a density of 100 cells per 35 cm2 flask
without feeder layer. Ten days later, four morphologically trans-
formed foci were cloned, expanded in culture and called Ta, Th,
Tc and Td respectively. They could be subcultured continuously
for over 60 population doublings. To assess theirneoplastic char-
acteristics, their anchorage independence growth nature was
determined by means of colony formation in soft agar. The
plating efficiency in soft agar increased with increasing passage
from 0.08% at passage 10 to 0.32% at passage 40 (Table 3). The
Tc, Td and cells of the 40th passage that demonstrated high
growth rate were further tested for their tumorigenicity in nude
mice. We found tumours at sites of injection in two out of three
nude mice in each group with a latency period ranging from
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Figure 1 Growth of SHE cells after irradiation with a-particles or/and
treatment with rhTNF-a. Data were pooled from 7 to 50 experiments.
C, untreated primary cells; C+T, primary cells treated with rhTNF-a only;
a, pnmary cells irradiated by a-particles only; a + T, primary cells treated
with rhTNF-a and a-particles irradiation, 0, C; A, a; A, C + T; *, a + T
1 to 3 months after innoculation (Table 4). All of these tumour
tissues were identified as poorly differentiated fibrosarcoma by
histopathological examination.
DISCUSSION
Carcinogenesis is a multistep process and may consist of three
major stages: initiation, promotion and progression. Many
agents, including a-particles and some endogenous inflamma-
tory agents, are carcinogenic (Lloyd et al, 1979; Roberts and
Goodhead, 1987; Bennett et al, 1993). In recent years, the studies
ofcancer risk due to exposure to densely ionizing radiation have
been focused on low doses of high LET a-particles as there is a
high lung cancer risk for uranium miners and exposure of the
lung to a-emiting radon daughter products, which represents the
largest component ofbackground radiation to the general public
(NCRP report no. 78, 1984).
The inflammatory milieu is considered to be very complex.
Among the numerous secretory products ofmacrophages, reactive
oxygen species (RO) have been shown to act as promoters in radia-
tion- or chemical-initiated mouse embryo fibroblasts (Borek and
Troll, 1983; Zimmerman and Cerutti, 1984; Owens et al, 1995).
Besides RO, there is evidence that arachidonic acidmetabolites and
PAF (1-O-alkyl-2-acetyl-glycero-3-phosphocholine) can induce
malignant transformation of murine fibroblasts (Zimmerman and
Cerutti, 1984; Floyd, 1990; Bennett et al, 1993). In this paper, we
demonstrate the potential ofTNF-a, a known endogenous inflam-
matory agent, in modulating the carcinogenic processes. Our
results, using concentration of TNF-a that may well be found in
vivo at sites of inflammation (Mohr et al, 1991; Donaldson et al,
Table 3 Agarcolonyformation ofa-irradiated SHE cells treated with rhTNF-aa
Passage Colony formation (%)
Primary 0
10th 0.078
20th 0.212
40th 0.320
60th 0.310
aThe cells suspended in agar medium were seeded on top of a base layer at
2 x 105 cells per dish. Ten dishes for each sample were prepared and
incubated in a 5% carbon dioxide-air incubator. After2 weeks, colonies more
than 0.1 mm in diameter were counted under a dissecting microscope.
Table 4 Proliferation ability and tumorigenicity of a-irradiated SHE cells
treated with rhTNF-a
Cells Proliferation Tumorigenicity progressively
ability (OD ± s.e.) growing tumoura
Primary 0.18 0/3
40th 0.38 2/3
Ta 0.24±0.30 NDb
Tb 0.33 ± 0.01 ND
Tc 0.38 2/3
Td 0.35 ± 0.05 2/3
BEL7402c ND 3/5
aNumberof mice with tumour/number of animals inoculated. bNot determined.
cHuman hepatoma cell line.
1992), provide a suggestion that this agent may relate to the malig-
nant transformation induced by a-particles. Our results not only
provide evidence for elucidating the mechanisms underlying
chronic inflammation andpredisposition to cancer, but also provide
a means for assessing cancerrisk as a result ofradiation exposure.
TNF-a can induce phenotypic alterations that are characteristic
ofmalignancy. Treatment ofSHE cells irradiated by a 0.5-Gy dose
of a-particles in combination with 600 U ml-' TNF-a in medium
induced an increase in their ability to (a) form neoplastic foci,
(b) reach a higher saturation density than non-TNF-a-treated cells
(data not shown), (c) sustain growth under low serum conditions
(data not shown), (d) acquire the property of anchorage indepen-
dence (Al) growth, and (c) form tumours in nude mice. Addition of
TNF-a to subcultures of irradiated SHE cells permitted their
continuous propagation. The growth of irradiated SHE cells
depended on the presence of rhTNF-a only within the first 30
passages, after which the cells could be subcultured in the absence
of rhTNF-a. In contrast, both TNF-a-treated control cells and a-
irradiated cells, without subsequent TNF-a treatment, senesced
after 7-15 passages. It seemed that TNF-a played a critical role in
the acquisition ofexpanded lifespan forthe a-irradiated SHE cells.
An anti-TNF-a -antibody could be used to prevent binding of
TNF-a to its receptor and to promote clearance ofTNF-afrom the
circulation via antigen-antibody complexes (Engelmann et al,
1990). In our experiment, the TF decreased significantly in the
presence of a 2 jg ml-' dose of anti-TNF-a antibody that could
neutralize the cytotoxicity due to 600 U ml-' TNF-a. However, the
TF was still much higher than that of cells exposed to a 0.5 Gy
dose of a-particles alone. This suggested the presence of other
known orunknown effectors thatcould act as tumourpromoters in
this supematant. On the other hand, it cannot be excluded that
feeders may release something that may cooperate with TNF-a to
increase the transformation frequency.
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In summary, the present study provides the first evidence that
administration of the endogenous inflammatory agent TNF-a
promotes malignant transformation induced by exposure to a-
particles. Our data suggest that TNF-a, released by activated
macrophages in and around areas ofchronic inflammation, may be
an important contributor to tumourpromotion.
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